iohexol has been researched along with Hepatocellular Carcinoma in 85 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Excerpt | Relevance | Reference |
---|---|---|
"To compare the efficacy of transcatheter arterial chemoembolization (TACE) using multiple anticancer drugs (epirubicin, cisplatin, mitomycin C, and 5-furuorouracil: Multi group) with TACE using epirubicin (EP group) for hepatocellular carcinoma (HCC)." | 9.16 | Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. ( Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sanda, H; Sato, M; Shirai, S; Sonomura, T; Tanaka, T, 2012) |
"The purpose of our study is to evaluate the distribution of acetic acid mixed with iodinated contrast agent during percutaneous acetic acid injection on CT fluoroscopy for hepatocellular carcinoma." | 7.72 | Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003) |
"The efficacy of transcatheter arterial Lipiodol chemoembolization (TALCE) using epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma (HCC) was assessed retrospectively." | 7.69 | Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma. ( Kanematsu, M, 1995) |
"To compare the efficacy of transcatheter arterial chemoembolization (TACE) using multiple anticancer drugs (epirubicin, cisplatin, mitomycin C, and 5-furuorouracil: Multi group) with TACE using epirubicin (EP group) for hepatocellular carcinoma (HCC)." | 5.16 | Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma. ( Ikoma, A; Kawai, N; Minamiguchi, H; Nakai, M; Nakata, K; Sahara, S; Sanda, H; Sato, M; Shirai, S; Sonomura, T; Tanaka, T, 2012) |
"To define the percentage of small (≤2 cm) hepatocellular carcinoma (HCC) nodules showing the diagnostic enhancement pattern at CEUS, computed tomography (CT), and gadobenate dimeglumine (Gd-BOPTA)-enhanced magnetic resonance (MR) imaging." | 3.79 | Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria. ( Angileri, R; Cabibbo, B; Cova, MA; De Paoli, L; Pizzolato, R; Quaia, E, 2013) |
"The purpose of our study is to evaluate the distribution of acetic acid mixed with iodinated contrast agent during percutaneous acetic acid injection on CT fluoroscopy for hepatocellular carcinoma." | 3.72 | Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent. ( Arrivé, L; Dahan, H; Fartoux, L; Lewin, M; Monnier-Cholley, L; Poupon, R; Rosmorduc, O; Tubiana, JM, 2003) |
"9 months) in 52 patients with hepatocellular carcinoma (HCC): An emulsion of Lipiodol and epirubicin was injected as selectively as possible in a dosage proportional to liver function and tumour size." | 3.69 | [The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy]. ( Brambs, HJ; Claussen, CD; Dette, S; Dietz, K; Duda, SH; Geissler, F; Huppert, PE; Lauchart, W, 1994) |
"The efficacy of transcatheter arterial Lipiodol chemoembolization (TALCE) using epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma (HCC) was assessed retrospectively." | 3.69 | Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma. ( Kanematsu, M, 1995) |
"In contrast, among patients with hepatocellular carcinoma, mean contrast enhancement in lesions in the arterial phase was significantly superior in group A compared with group B." | 2.69 | Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials. ( Balzer, J; Clauss, W; Felfe, R; Felix, R; Hänninen, EL; Pegios, W; Vogl, TJ, 2000) |
"Pathology confirmed hepatocellular carcinoma (HCC) in 3 atypical nodules and FNH-like histology in 3 atypical and 4 typical nodules." | 1.46 | Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma. ( Fidler, JL; Hough, DM; Kamath, PS; Poterucha, JT; Venkatesh, SK; Wells, ML, 2017) |
"DECT was applied in 46 patients with hepatocellular carcinoma (HCC) prior to RE." | 1.42 | Impact of dual-energy CT prior to radioembolization (RE). ( Altenbernd, JC; Forsting, M; Heusner, T; Lauenstein, T; Nagarajah, J; Ringelstein, A; Theysohn, JM; Umutlu, L; von der Stein, I; Wetter, A, 2015) |
"Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning." | 1.40 | Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization. ( Choi, SJ; Kim, HS; Kim, J; Lee, JM; Park, H; Seo, J, 2014) |
"Although hepatocellular carcinoma (HCC) demonstrates characteristic hypervascularity, some HCCs have a hypovascular pattern on computed tomography (CT)." | 1.38 | Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma. ( Chung, GE; Jang, JJ; Kim, SH; Kim, YJ; Lee, HS; Lee, JH; Lee, JM; Lee, K; Myung, SJ; Suh, KS; Yoon, JH, 2012) |
"Twenty-four hepatocellular carcinomas were targeted in 18 patients (14 men, four women; mean age, 66 years), and segmental or lobar chemoembolization with intraprocedural transcatheter intraarterial perfusion MRI was successful in all 18." | 1.38 | Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI. ( Gaba, RC; Jin, B; Larson, AC; Lewandowski, RJ; Omary, RA; Ragin, AB; Salem, R; Wang, D, 2012) |
"Most patients with HCC have coexisting liver cirrhosis (LC) at the time of diagnosis." | 1.37 | Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization. ( Bae, EJ; Chang, SH; Cho, HS; Kang, Y; Kim, HJ; Park, DJ; Seo, JW, 2011) |
"To describe imaging findings of early hepatocellular carcinoma (HCC) at gadoxetic acid-enhanced magnetic resonance (MR) imaging, dynamic contrast material-enhanced computed tomography (CT), CT during arterial portography (CTAP), and CT during hepatic arteriography (CTHA) and to compare the diagnostic performance of each modality for small (≤ 2 cm) HCC." | 1.37 | Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. ( Araki, T; Asakawa, M; Enomoto, N; Fujii, H; Ichikawa, T; Kitamura, T; Matsuda, M; Motosugi, U; Muhi, AM; Nakano, M; Nakazawa, T; Sakamoto, M; Sano, K; Sou, H, 2011) |
"In 20 patients with hepatocellular carcinomas, multiphasic liver CT scans including arterial, portal, and equilibrium phases were performed." | 1.36 | Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies. ( Cho, SH; Choi, BI; Han, JK; Kim, KS; Kim, KW; Kim, SH; Kim, SJ; Lee, JM, 2010) |
"Fifteen patients with either hepatocellular carcinoma (HCC, n = 8) or hypervascular liver metastases from uveal melanoma (n = 7) underwent arterial and portal venous C-arm CT of the liver using intraarterial contrast media administration directly before TACE." | 1.35 | Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCT. ( Borchert, M; Frericks, BB; Justiz, J; Martus, P; Meyer, BC; Voges, M; Wacker, FK; Wolf, KJ, 2008) |
"To investigate the risk factors for local tumor progression after radiofrequency (RF) ablation combined with chemoembolization for the treatment of hepatocellular carcinoma (HCC)." | 1.34 | Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression. ( Fuke, H; Murata, K; Nakatsuka, A; Shiraki, K; Takaki, H; Takeda, K; Yamakado, K, 2007) |
"We applied it for a case of hepatocellular carcinoma with good result." | 1.28 | [Successful preparation of mitoxantrone emulsion containing non-ionic contrast medium]. ( Hirayama, R; Ichikawa, W; Kawachi, Y; Mishima, Y; Nihei, Z; Sawai, S; Tamaru, H; Uetake, H; Yamashita, T, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (14.12) | 18.2507 |
2000's | 24 (28.24) | 29.6817 |
2010's | 48 (56.47) | 24.3611 |
2020's | 1 (1.18) | 2.80 |
Authors | Studies |
---|---|
Hu, HT | 1 |
Shan, QY | 1 |
Chen, SL | 1 |
Li, B | 1 |
Feng, ST | 1 |
Xu, EJ | 1 |
Li, X | 1 |
Long, JY | 1 |
Xie, XY | 1 |
Lu, MD | 1 |
Kuang, M | 1 |
Shen, JX | 1 |
Wang, W | 1 |
Jia, GS | 1 |
Feng, GL | 1 |
Li, JP | 1 |
Xu, HL | 1 |
Wang, H | 2 |
Cheng, YP | 1 |
Yan, LL | 1 |
Jiang, HJ | 1 |
Wells, ML | 1 |
Hough, DM | 1 |
Fidler, JL | 1 |
Kamath, PS | 1 |
Poterucha, JT | 1 |
Venkatesh, SK | 1 |
Sun, W | 1 |
Ding, XY | 1 |
Chen, JL | 1 |
Li, WD | 1 |
Wang, XY | 1 |
Guo, XD | 1 |
Shen, YJ | 1 |
Sun, SS | 1 |
Lin, EY | 1 |
Lee, RC | 1 |
Guo, WY | 1 |
Wu, FC | 1 |
Gehrisch, S | 1 |
Kowarschik, M | 1 |
Zhang, L | 1 |
Wang, N | 1 |
Mao, J | 1 |
Liu, X | 1 |
Gao, Z | 1 |
Dai, X | 1 |
Feng, B | 1 |
Nakano, MM | 1 |
Yamamoto, A | 1 |
Nishida, N | 1 |
Hamuro, M | 1 |
Hamamoto, S | 1 |
Jogo, A | 1 |
Sohgawa, E | 1 |
Kageyama, K | 1 |
Minami, T | 1 |
Miki, Y | 1 |
Woo, S | 2 |
Lee, JM | 5 |
Yoon, JH | 4 |
Joo, I | 1 |
Kim, SH | 4 |
Lee, JY | 1 |
Kim, YJ | 3 |
Han, JK | 3 |
Choi, BI | 3 |
Chung, JW | 3 |
Hur, S | 2 |
Joo, SM | 1 |
Kim, HC | 2 |
Jae, HJ | 2 |
Park, JH | 2 |
Yu, MH | 1 |
Baek, JH | 1 |
Flohr, TG | 1 |
Ichikawa, T | 5 |
Motosugi, U | 2 |
Morisaka, H | 1 |
Sano, K | 2 |
Ali, M | 1 |
Araki, T | 2 |
Okada, M | 2 |
Kondo, H | 3 |
Sou, H | 3 |
Murakami, T | 2 |
Kanematsu, M | 4 |
Yoshikawa, S | 3 |
Shiosakai, K | 2 |
Hayakawa, A | 2 |
Awai, K | 3 |
Yoshimitsu, K | 2 |
Yamashita, Y | 4 |
Quaia, E | 1 |
De Paoli, L | 1 |
Angileri, R | 1 |
Pizzolato, R | 1 |
Cabibbo, B | 1 |
Cova, MA | 1 |
Kim, KA | 1 |
Kim, MJ | 3 |
Choi, JY | 1 |
Park, MS | 2 |
Lim, JS | 1 |
Chung, YE | 1 |
Kim, KW | 2 |
Choi, SJ | 1 |
Kim, J | 2 |
Seo, J | 1 |
Kim, HS | 1 |
Park, H | 1 |
Tan, B | 1 |
Zhao, B | 1 |
Gong, G | 1 |
Xu, Z | 1 |
Burgmans, MC | 1 |
van Erkel, AR | 1 |
Too, CW | 1 |
Coenraad, M | 1 |
Lo, RH | 1 |
Tan, BS | 1 |
Hoffmann, R | 1 |
Rempp, H | 1 |
Syha, R | 1 |
Ketelsen, D | 1 |
Pereira, PL | 2 |
Claussen, CD | 3 |
Clasen, S | 1 |
Altenbernd, JC | 1 |
von der Stein, I | 1 |
Wetter, A | 1 |
Nagarajah, J | 1 |
Umutlu, L | 1 |
Heusner, T | 1 |
Theysohn, JM | 1 |
Ringelstein, A | 1 |
Forsting, M | 1 |
Lauenstein, T | 1 |
Kaufmann, S | 2 |
Schulze, M | 2 |
Spira, D | 1 |
Horger, M | 2 |
Chung, BM | 1 |
Park, HJ | 1 |
Park, SB | 1 |
Lee, JB | 1 |
Ahn, HS | 1 |
Kim, YS | 5 |
Lewin, M | 2 |
Gelu-Simeon, M | 1 |
Ostos, M | 1 |
Boufassa, F | 1 |
Sobesky, R | 1 |
Teicher, E | 1 |
Meyer, L | 1 |
Fontaine, H | 1 |
Salmon-Céron, D | 1 |
Samuel, D | 1 |
Seror, O | 1 |
Trinchet, JC | 1 |
Duclos-Vallée, JC | 1 |
Horger, T | 1 |
Oelker, A | 1 |
Nikolaou, K | 1 |
Duan, F | 1 |
Wang, EQ | 1 |
Lam, MG | 1 |
Abdelmaksoud, MH | 1 |
Louie, JD | 1 |
Hwang, GL | 1 |
Kothary, N | 1 |
Kuo, WT | 1 |
Hofmann, LV | 1 |
Sze, DY | 1 |
Iwai, S | 1 |
Okano, S | 1 |
Chikazawa, S | 1 |
Kakizaki, T | 1 |
Sakonju, I | 1 |
Solomon, JA | 1 |
Liu, QY | 1 |
He, CD | 1 |
Zhou, Y | 2 |
Huang, D | 1 |
Lin, H | 1 |
Wang, Z | 1 |
Wang, D | 3 |
Wang, JQ | 1 |
Liao, LP | 1 |
Ehman, EC | 1 |
Behr, SC | 1 |
Umetsu, SE | 1 |
Fidelman, N | 1 |
Yeh, BM | 1 |
Ferrell, LD | 1 |
Hope, TA | 1 |
Zhao, YJ | 1 |
Chen, WX | 1 |
Wu, DS | 1 |
Zhang, WY | 1 |
Zheng, LR | 1 |
Li, R | 1 |
Cai, P | 1 |
Ma, KS | 1 |
Ding, SY | 1 |
Guo, DY | 1 |
Yan, XC | 1 |
He, L | 1 |
Huang, Y | 1 |
Chen, S | 1 |
Wu, P | 1 |
Ye, W | 1 |
Liu, Z | 1 |
Liang, C | 1 |
Choi, JW | 1 |
Lee, JH | 2 |
Yu, SJ | 1 |
Cho, EJ | 1 |
Kim, MU | 1 |
Lee, M | 1 |
Kim, EY | 1 |
Choi, D | 5 |
Lim, DH | 1 |
Lee, WJ | 2 |
Yoo, BC | 1 |
Paik, SW | 1 |
Chen, G | 1 |
Ma, DQ | 1 |
He, W | 1 |
Zhang, BF | 1 |
Zhao, LQ | 1 |
Kubas, A | 1 |
Chapet, O | 1 |
Merle, P | 1 |
Lorchel, F | 1 |
d'Hombres, A | 1 |
Mornex, F | 1 |
Balci, NC | 1 |
Befeler, AS | 1 |
Bieneman, BK | 1 |
Fattahi, R | 1 |
Saglam, S | 1 |
Havlioglu, N | 1 |
Matoba, M | 1 |
Kitadate, M | 1 |
Kondou, T | 1 |
Yokota, H | 1 |
Tonami, H | 1 |
Park, Y | 1 |
Rhim, H | 4 |
Lim, HK | 4 |
Choi, JI | 1 |
Choi, HJ | 1 |
Jung, DC | 1 |
Hong, EK | 1 |
Park, JW | 1 |
Jang, YJ | 1 |
Kim, CM | 1 |
Kim, KS | 1 |
Kim, SJ | 1 |
Cho, SH | 1 |
Nakai, M | 2 |
Sato, M | 2 |
Ikoma, A | 2 |
Nakata, K | 2 |
Sahara, S | 2 |
Takasaka, I | 1 |
Minamiguchi, H | 2 |
Kawai, N | 2 |
Sonomura, T | 2 |
Kishi, K | 1 |
Kim, JH | 1 |
Yoon, HK | 1 |
Ko, GY | 1 |
Gwon, DI | 1 |
Jang, CS | 1 |
Song, HY | 1 |
Shin, JH | 1 |
Sung, KB | 1 |
Kim, JE | 1 |
Lee, MW | 3 |
Shin, SW | 1 |
Cho, SK | 1 |
Chung, GE | 1 |
Myung, SJ | 1 |
Lee, K | 1 |
Jang, JJ | 1 |
Suh, KS | 1 |
Lee, HS | 1 |
Cho, HS | 1 |
Seo, JW | 1 |
Kang, Y | 1 |
Bae, EJ | 1 |
Kim, HJ | 1 |
Chang, SH | 1 |
Park, DJ | 1 |
Yuan, Z | 1 |
Ye, XD | 1 |
Dong, S | 1 |
Xu, LC | 1 |
Xiao, XS | 1 |
Muhi, AM | 1 |
Matsuda, M | 1 |
Nakano, M | 1 |
Sakamoto, M | 1 |
Nakazawa, T | 1 |
Asakawa, M | 1 |
Fujii, H | 1 |
Kitamura, T | 1 |
Enomoto, N | 1 |
Tanaka, T | 1 |
Sanda, H | 1 |
Shirai, S | 1 |
Gaba, RC | 1 |
Jin, B | 1 |
Lewandowski, RJ | 2 |
Ragin, AB | 1 |
Larson, AC | 2 |
Salem, R | 2 |
Omary, RA | 2 |
Cha, DI | 1 |
Chung, WS | 1 |
Lee, KH | 1 |
Lee, YJ | 1 |
Kwon, J | 1 |
Baek, SE | 1 |
Bova, V | 1 |
Miraglia, R | 1 |
Maruzzelli, L | 1 |
Vizzini, GB | 1 |
Luca, A | 1 |
Lee, HY | 1 |
Park, MJ | 1 |
Kim, YK | 1 |
Choi, YA | 1 |
Kim, CK | 1 |
Park, BK | 1 |
Kim, B | 1 |
Lee, JA | 1 |
Jeong, WK | 1 |
Kim, Y | 1 |
Song, SY | 2 |
Heo, JN | 1 |
Park, CK | 1 |
Liu, YI | 1 |
Shin, LK | 1 |
Jeffrey, RB | 1 |
Kamaya, A | 1 |
Hayashi, M | 1 |
Matsui, O | 1 |
Ueda, K | 1 |
Kawamori, Y | 1 |
Gabata, T | 1 |
Kadoya, M | 1 |
Arrivé, L | 1 |
Rosmorduc, O | 1 |
Dahan, H | 1 |
Fartoux, L | 1 |
Monnier-Cholley, L | 1 |
Poupon, R | 1 |
Tubiana, JM | 1 |
Lin, J | 1 |
Zhou, KR | 1 |
Chen, ZW | 1 |
Wang, JH | 1 |
Yan, ZP | 1 |
Wang, YX | 1 |
Inoue, M | 1 |
Yagyu, Y | 1 |
Watanabe, M | 1 |
Sano, T | 1 |
Nin, S | 1 |
Koike, R | 1 |
Nishimura, Y | 1 |
Lu, DS | 2 |
Yu, NC | 1 |
Raman, SS | 1 |
Limanond, P | 1 |
Lassman, C | 1 |
Murray, K | 1 |
Tong, MJ | 1 |
Amado, RG | 1 |
Busuttil, RW | 1 |
Yoshikawa, T | 1 |
Ohno, Y | 1 |
Motohara, T | 1 |
Mitchell, DG | 1 |
Sugimoto, K | 1 |
Matsumoto, S | 1 |
Hirota, S | 1 |
Sugimura, K | 1 |
Lim, HG | 1 |
Goshima, S | 1 |
Yokoyama, R | 1 |
Miyoshi, T | 1 |
Nishibori, H | 1 |
Kato, H | 1 |
Hoshi, H | 1 |
Onozuka, M | 1 |
Moriyama, N | 1 |
Yenarkarn, P | 1 |
Thoeni, RF | 1 |
Hanks, D | 1 |
Takaki, H | 1 |
Yamakado, K | 1 |
Nakatsuka, A | 1 |
Fuke, H | 1 |
Murata, K | 1 |
Shiraki, K | 1 |
Takeda, K | 1 |
Tatsugami, F | 1 |
Matsuki, M | 1 |
Nakai, G | 1 |
Tanikake, M | 1 |
Narabayashi, I | 1 |
Miyaji, K | 1 |
Asai, A | 1 |
Fujiwara, S | 1 |
Hongo, Y | 1 |
Katsu, K | 1 |
Graham, JM | 1 |
Atassi, B | 1 |
Sato, KT | 1 |
Ryu, RK | 1 |
Nemcek, AA | 1 |
Mulcahy, MF | 1 |
Kulik, LM | 1 |
Miller, FH | 1 |
Meyer, BC | 1 |
Frericks, BB | 1 |
Voges, M | 1 |
Borchert, M | 1 |
Martus, P | 1 |
Justiz, J | 1 |
Wolf, KJ | 1 |
Wacker, FK | 1 |
Huppert, PE | 1 |
Geissler, F | 1 |
Duda, SH | 1 |
Lauchart, W | 1 |
Dette, S | 1 |
Dietz, K | 1 |
Brambs, HJ | 1 |
Ohtomo, K | 1 |
Takahashi, S | 1 |
Ohashi, I | 1 |
Ina, H | 1 |
Okada, Y | 1 |
Yoshida, T | 1 |
Gomi, N | 1 |
Himeno, Y | 1 |
Hanafusa, K | 1 |
Shibuya, H | 1 |
Arakawa, A | 1 |
Nishiharu, T | 1 |
Matsukawa, T | 1 |
Urata, J | 1 |
Hatanaka, Y | 1 |
Takahashi, M | 1 |
Kanemitsu, K | 1 |
Mihara, M | 1 |
Lee, HM | 1 |
Krasny, RM | 1 |
Busuttil, R | 1 |
Kadell, B | 1 |
Lucas, J | 1 |
Pacella, CM | 1 |
Bizzarri, G | 1 |
Anelli, V | 1 |
Valle, D | 1 |
Fabbrini, R | 1 |
Bianchini, A | 1 |
Fenderico, P | 1 |
Rossi, Z | 1 |
Ohgiya, Y | 1 |
Gokan, T | 1 |
Munechika, H | 1 |
Luboldt, W | 1 |
Straub, J | 1 |
Seemann, M | 1 |
Helmberger, T | 1 |
Reiser, M | 1 |
Kopka, L | 1 |
Grabbe, E | 1 |
Hänninen, EL | 1 |
Vogl, TJ | 1 |
Felfe, R | 1 |
Pegios, W | 1 |
Balzer, J | 1 |
Clauss, W | 1 |
Felix, R | 1 |
Mehnert, F | 1 |
Trübenbach, J | 1 |
Kopp, AF | 1 |
Moteki, T | 1 |
Horikoshi, H | 1 |
Oya, N | 1 |
Aoki, J | 1 |
Endo, K | 1 |
Ichikawa, W | 1 |
Nihei, Z | 1 |
Sawai, S | 1 |
Yamashita, T | 1 |
Uetake, H | 1 |
Kawachi, Y | 1 |
Hirayama, R | 1 |
Mishima, Y | 1 |
Tamaru, H | 1 |
Berde, CB | 1 |
Sethna, NF | 1 |
Fisher, DE | 1 |
Kahn, CH | 1 |
Chandler, P | 1 |
Grier, HE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Artificial Intelligent Prognostic Assessment and Pathological Basis Research of Early Primary Hepatocellular Carcinoma After Minimally Invasive Treatment Based on Multimodal MRI and Clinical Big Data[NCT04299919] | 1,200 participants (Anticipated) | Observational | 2007-04-01 | Active, not recruiting | |||
Recurrence Risk Factors of Early-Stage Hepatocellular Carcinoma After Radio Frequency Ablation: a Multi-center Prospective Case-control Study[NCT02046356] | 139 participants (Actual) | Observational [Patient Registry] | 2014-01-31 | Active, not recruiting | |||
Low Dose Multi-arterial Phase CT Imaging for Improved Detection of Liver Tumors and Pancreatic Masses[NCT04813432] | 50 participants (Actual) | Observational | 2018-09-10 | Active, not recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for iohexol and Hepatocellular Carcinoma
Article | Year |
---|---|
CT findings of primary clear cell carcinoma of liver: with analysis of 19 cases and review of the literature.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Ioh | 2014 |
8 trials available for iohexol and Hepatocellular Carcinoma
Article | Year |
---|---|
Volumetric low-tube-voltage CT imaging for evaluating hypervascular hepatocellular carcinoma; effects on radiation exposure, image quality, and diagnostic performance.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver; Liver Neoplasms; Ma | 2013 |
Change in contrast enhancement of HCC on 1-month follow-up CT after local radiotherapy: an early predictor of final treatment response.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; | 2009 |
Depiction of hypervascular hepatocellular carcinoma with 64-MDCT: comparison of moderate- and high-concentration contrast material with and without saline flush.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Carcinoma, Hepatocellular; Chi-Square Distribu | 2009 |
Prospective evaluation of transcatheter arterial chemoembolization (TACE) with multiple anti-cancer drugs (epirubicin, cisplatin, mitomycin c, 5-fluorouracil) compared with TACE with epirubicin for treatment of hepatocellular carcinoma.
Topics: Aged; Aged, 80 and over; Angiography; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hep | 2012 |
Gadolinium-enhanced phase-contrast magnetic resonance portography.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Colorectal Neoplasms; Contrast Media; Female; Gadolinium DTP | 2005 |
MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.
Topics: Aged; Aged, 80 and over; Aortography; Carcinoma, Hepatocellular; Contrast Media; Female; Hepatic Art | 2006 |
Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Carcinoma, Hepatocellular; Contrast Media; Double-Blind Metho | 2000 |
Biphasic spiral CT of the liver: automatic bolus tracking or time delay?
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Image Processing, Computer-A | 2001 |
76 other studies available for iohexol and Hepatocellular Carcinoma
Article | Year |
---|---|
CT-based radiomics for preoperative prediction of early recurrent hepatocellular carcinoma: technical reproducibility of acquisition and scanners.
Topics: Adult; Aged; Algorithms; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Hepat | 2020 |
Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients.
Topics: Adult; Aged; Aged, 80 and over; Area Under Curve; Carcinoma, Hepatocellular; Case-Control Studies; C | 2017 |
Benign nodules in post-Fontan livers can show imaging features considered diagnostic for hepatocellular carcinoma.
Topics: Adolescent; Adult; Carcinoma, Hepatocellular; Child; Contrast Media; Diagnosis, Differential; Female | 2017 |
[The combination of percutaneous iohexol-ethanol injection with radiofrequency ablation for the treatment of primary liver cancer in high-risk locations].
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modality Ther | 2017 |
Three-Dimensional Quantitative Color-Coding Analysis of Hepatic Arterial Flow Change during Chemoembolization of Hepatocellular Carcinoma.
Topics: Aged; Aged, 80 and over; Angiography; Angiography, Digital Subtraction; Blood Flow Velocity; Carcino | 2018 |
Dual-Energy CT-Derived Volumetric Iodine Concentration for the Assessment of Therapeutic Response after Microwave Ablation in a Rabbit Model with Intrahepatic VX2 Tumor.
Topics: Ablation Techniques; Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Contrast Media; Iohexol; | 2018 |
Risk factors for local recurrence of hepatocellular carcinoma after transcatheter arterial chemoembolization with drug-eluting beads (DEB-TACE).
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antibiotics, Antineoplastic; Carci | 2019 |
Small- and medium-sized hepatocellular carcinomas: monopolar radiofrequency ablation with a multiple-electrode switching system-mid-term results.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female | 2013 |
Liver abscess after transarterial chemoembolization in patients with bilioenteric anastomosis: frequency and risk factors.
Topics: Adult; Aged; Anastomosis, Surgical; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contr | 2013 |
Low tube voltage intermediate tube current liver MDCT: sinogram-affirmed iterative reconstruction algorithm for detection of hypervascular hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Algorithms; Analysis of Variance; Carcinoma, Hepatocellular; Contras | 2013 |
Recommended iodine dose for multiphasic contrast-enhanced mutidetector-row computed tomography imaging of liver for assessing hypervascular hepatocellular carcinoma: multicenter prospective study in 77 general hospitals in Japan.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Dose-Response Relationship, Drug; Female; Hospitals | 2013 |
Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; Humans; Im | 2013 |
Detection of recurrent hepatocellular carcinoma on post-operative surveillance: comparison of MDCT and gadoxetic acid-enhanced MRI.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Iohexol; Liver Neo | 2014 |
Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
Topics: Aged; Area Under Curve; Biomarkers, Tumor; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic | 2014 |
Pilot study evaluating catheter-directed contrast-enhanced ultrasound compared to catheter-directed computed tomography arteriography as adjuncts to digital subtraction angiography to guide transarterial chemoembolization.
Topics: Aged; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Catheters; Chemoembolization, The | 2014 |
Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
Topics: Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, | 2014 |
[Multicenter trial for optimization of bolus tracking settings and contrast material injection protocol in arterial dominant phase of dynamic computed tomography for diagnosis of hepatocellular carcinoma].
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Hepatic Artery; Humans; Injections, Intra-A | 2014 |
Impact of dual-energy CT prior to radioembolization (RE).
Topics: Aged; Angiography; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Contrast Media; Embo | 2015 |
Comparison of volume perfusion computed tomography and contrast-enhanced ultrasound for assessment of therapeutic effect of transarterial chemoembolization in patients with hepatocellular carcinoma: a preliminary report.
Topics: Aged; Aged, 80 and over; Blood Volume; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Co | 2016 |
Differentiation of small arterial enhancing hepatocellular carcinoma from non-tumorous arterioportal shunt with an emphasis on the precontrast CT scan.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; | 2015 |
Imaging Features and Prognosis of Hepatocellular Carcinoma in Patients with Cirrhosis Who Are Coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Coinfection; Contrast Media; Diagnostic Imaging; Female; Fra | 2015 |
Reproducibility of VPCT parameters in the normal pancreas: comparison of two different kinetic calculation models.
Topics: Adult; Aged; Blood Volume; Carcinoma, Hepatocellular; Cone-Beam Computed Tomography; Contrast Media; | 2015 |
Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion.
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Chemoem | 2016 |
Transcatheter arterial embolization for treatment of hepatocellular carcinoma in a cat.
Topics: Animals; Carcinoma, Hepatocellular; Cat Diseases; Cats; Chemoembolization, Therapeutic; Contrast Med | 2015 |
Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization.
Topics: Adult; Aged; Angiography, Digital Subtraction; Carcinoma, Hepatocellular; Chemoembolization, Therape | 2016 |
Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Hepatectomy; Humans; Iohexol; Liver Neoplasms; Li | 2016 |
Differentiation of mass-forming intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma: based on the multivariate analysis of contrast-enhanced computed tomography findings.
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contra | 2016 |
Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Contrast Media; Diagn | 2016 |
CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Hepatocellular; Contrast Media; Female; Hepatectomy; Huma | 2017 |
Cone Beam CT-Guided Chemoembolization of Probable Hepatocellular Carcinomas Smaller than 1 cm in Patients at High Risk of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cone-Beam Computed Tomography; Contrast M | 2017 |
Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Blood Volume; Carcinoma, Hepatocel | 2008 |
[Dosimetric impact of breath-hold in the treatment of hepatocellular carcinoma by conformal radiation therapy].
Topics: Carcinoma, Hepatocellular; Contrast Media; Duodenum; Exhalation; France; Humans; Inhalation; Iohexol | 2009 |
Fat containing HCC: findings on CT and MRI including serial contrast-enhanced imaging.
Topics: Adipose Tissue; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Hum | 2009 |
Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression.
Topics: Aged; Arteries; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Disease Progression; F | 2009 |
Diagnostic value of early-phase-enhanced computed tomography for the differentiation of pulmonary metastases from hepatocellular carcinoma and primary lung cancer.
Topics: Adolescent; Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Female; | 2009 |
Image fusion in dual energy computed tomography for detection of hypervascular liver hepatocellular carcinoma: phantom and preliminary studies.
Topics: Adult; Aged; Analysis of Variance; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexo | 2010 |
Triple-phase computed tomography during arterial portography with bolus tracking for hepatic tumors.
Topics: Aged; Carcinoma, Hepatocellular; Contrast Media; Digestive System Neoplasms; Female; Hepatitis C; Hu | 2010 |
Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cholangiocarcinoma; Cisplati | 2010 |
Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Carcinoma, Hepatocellular; Catheter Ablation; Contra | 2011 |
Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Hepatocellular; Chi-Square Distribution; Contrast Media; Female; Human | 2012 |
Incidence and risk factors for radiocontrast-induced nephropathy in patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization.
Topics: Acute Kidney Injury; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media | 2011 |
Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Ethiodized O | 2011 |
Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
Topics: Aged; Carcinoma, Hepatocellular; Chi-Square Distribution; Contrast Media; Early Diagnosis; Female; G | 2011 |
Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI.
Topics: Aged; Carcinoma, Hepatocellular; Catheterization; Chemoembolization, Therapeutic; Cisplatin; Contras | 2012 |
Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Humans; Image Enhancement; Ima | 2012 |
Enhancement patterns of hepatocellular carcinoma after transarterial chemoembolization using drug-eluting beads on arterial phase CT images: a pilot retrospective study.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; | 2012 |
Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies.
Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Contrast | 2013 |
Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors.
Topics: Aged; Biopsy; Carcinoma, Hepatocellular; Case-Control Studies; Catheter Ablation; Contrast Media; Di | 2013 |
Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Carcinoma, Hepatocellular; Carcinoma, Renal Cell; Contrast Med | 2013 |
Dual-energy CT to detect recurrent HCC after TACE: initial experience of color-coded iodine CT imaging.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; | 2013 |
Quantitatively defining washout in hepatocellular carcinoma.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver; Liver Neopla | 2013 |
Progression to hypervascular hepatocellular carcinoma: correlation with intranodular blood supply evaluated with CT during intraarterial injection of contrast material.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Disease Progression; Female; Hepatic Artery; | 2002 |
Percutaneous acetic acid injection for hepatocellular carcinoma: using CT fluoroscopy to evaluate distribution of acetic acid mixed with an iodinated contrast agent.
Topics: Acetic Acid; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Female; Fluo | 2003 |
3D contrast-enhanced MR portography and direct X-ray portography: a correlation study.
Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Female; Gadolinium DTPA; Humans; Hypertension, Por | 2003 |
Moderate versus high concentration of contrast material for aortic and hepatic enhancement and tumor-to-liver contrast at multi-detector row CT.
Topics: Adult; Aged; Aged, 80 and over; Aortography; Body Weight; Carcinoma, Hepatocellular; Contrast Media; | 2004 |
Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Humans; Iohexol; | 2005 |
Nonhepatic arteries originating from the hepatic arteries: angiographic analysis in 250 patients.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Angiography, Digital Subtraction; Carcinoma, Hepatocell | 2006 |
Case 107: lymphoma of the mesentery.
Topics: Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; Diatrizoate Meglumine; Hepatitis | 2007 |
Radiofrequency ablation combined with chemoembolization for the treatment of hepatocellular carcinomas 5 cm or smaller: risk factors for local tumor progression.
Topics: Aged; Carcinoma, Hepatocellular; Catheter Ablation; Chemoembolization, Therapeutic; Combined Modalit | 2007 |
Hepatic computed tomography for simultaneous depiction of hepatocellular carcinoma, intrahepatic portal veins, and hepatic veins in real-time virtual sonography: initial experience.
Topics: Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female; Hepat | 2007 |
Isolation of peroxisomes from tissues and cells by differential and density gradient centrifugation.
Topics: Animals; Biomarkers; Carcinoma, Hepatocellular; Cell Fractionation; Cell Line, Tumor; Centrifugation | 2001 |
Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cisplatin; Contrast Media; Doxorubi | 2008 |
Visualization of hypervascular liver lesions During TACE: comparison of angiographic C-arm CT and MDCT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Diagnosis, D | 2008 |
[The chemoembolization of hepatocellular carcinoma: the computed tomographic findings and clinical results in prospective repetitive therapy].
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Clinical Protocols; Contrast | 1994 |
Transcatheter arterial chemoembolization therapy with epirubicin hydrochloride, mitomycin C-iohexol-Lipiodol emulsion (EMILE) for hepatocellular carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Catheterizat | 1995 |
Hepatocellular carcinoma: detection with double-phase helical CT during arterial portography.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver Neoplasms; Ma | 1996 |
Segmental anatomy of the liver under the right diaphragmatic dome: evaluation with axial CT.
Topics: Angiography; Carcinoma, Hepatocellular; Contrast Media; Diaphragm; Embolization, Therapeutic; Hepati | 1996 |
Detection of hepatocellular carcinoma by intraarterially enhanced ultrasonography with CO2 microbubbles. Comparison with DSA, dynamic CT, and Lipiodol CT.
Topics: Angiography, Digital Subtraction; Carbon Dioxide; Carcinoma, Hepatocellular; Chemoembolization, Ther | 1996 |
Hepatic lesion characterization in cirrhosis: significance of arterial hypervascularity on dual-phase helical CT.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver; Liver Cirrho | 1997 |
Evaluation of the vascular pattern of hepatocellular carcinoma with dynamic computed tomography and its use in identifying optimal temporal windows for helical computed tomography.
Topics: Aged; Aorta, Abdominal; Carcinoma, Hepatocellular; Contrast Media; Evaluation Studies as Topic; Fema | 1998 |
Demonstration of aberrant hepatic and gastric arteries with helical CT.
Topics: Adult; Aged; Aged, 80 and over; Angiography; Carcinoma, Hepatocellular; Celiac Artery; Contrast Medi | 1999 |
Effective contrast use in CT angiography and dual-phase hepatic CT performed with a subsecond scanner.
Topics: Angiography; Carcinoma, Hepatocellular; Contrast Media; Female; Hemangioma; Humans; Injections, Intr | 1999 |
[Biphasic liver diagnosis with multiplanar-detector spiral CT].
Topics: Adult; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Iohexol; Liver; Liver Neoplasms; M | 1999 |
Evaluation of hepatic lesions and hepatic parenchyma using diffusion-weighted reordered turboFLASH magnetic resonance images.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Contrast Media; Diagnosis, Differential; | 2002 |
[Successful preparation of mitoxantrone emulsion containing non-ionic contrast medium].
Topics: Carcinoma, Hepatocellular; Delayed-Action Preparations; Drug Therapy, Combination; Emulsions; Humans | 1992 |
Celiac plexus blockade for a 3-year-old boy with hepatoblastoma and refractory pain.
Topics: Bupivacaine; Carcinoma, Hepatocellular; Celiac Plexus; Child, Preschool; Ethanol; Humans; Iohexol; L | 1990 |